Xiao-Mei Huang , Yue Xu , Si-Mei Qin , Ming-Xiong Tan , Qi-Pin Qin , Tai-Ming Shao , Hong Liang
{"title":"基于8-羟基喹啉的六种新型双核钙(II)配合物抗癌作用的研究","authors":"Xiao-Mei Huang , Yue Xu , Si-Mei Qin , Ming-Xiong Tan , Qi-Pin Qin , Tai-Ming Shao , Hong Liang","doi":"10.1016/j.jinorgbio.2025.113055","DOIUrl":null,"url":null,"abstract":"<div><div>This study reports the synthesis and antitumor evaluation of six novel dinuclear calcium(II) complexes with the general formula [Ca<sub>2</sub>(<em>μ</em><sub>2</sub>-O)<sub>2</sub>(QM<sup>x</sup>)<sub>4</sub>(QH<sup>y</sup>)<sub>2</sub>], designated as <strong>CaQ1</strong> through <strong>CaQ6</strong>. These complexes incorporate various deprotonated 8-hydroxyquinoline ligands (H-QM<sup>1</sup>−H-QM<sup>4</sup>) and 1,10-phenanthroline derivatives (QH<sup>2</sup>), synthesized using Ca(NO<sub>3</sub>)<sub>2</sub>·4H<sub>2</sub>O. The specific compositions are as follows: <strong>CaQ1:</strong> H-QM<sup>1</sup> = 5,7-dibromo-8-hydroxyquinoline (x = 1), QH<sup>1</sup> = bathophenanthroline; <strong>CaQ2:</strong> H-QM<sup>2</sup> = 5,7-dichloro-8-quinolinol (x = 2), QH<sup>1</sup> = bathophenanthroline; <strong>CaQ3:</strong> H-QM<sup>3</sup> = 5,7-diiodo-8-hydroxyquinoline (x = 3), QH<sup>2</sup> = 1,10-phenanthroline; <strong>CaQ4:</strong> H-QM<sup>2</sup> = 5,7-dichloro-8-quinolinol (x = 2), QH<sup>2</sup> = 1,10-phenanthroline; <strong>CaQ5:</strong> H-QM<sup>4</sup> = clioquinol (x = 4), QH<sup>2</sup> = 1,10-phenanthroline; <strong>CaQ6:</strong> H-QM<sup>1</sup> = 5,7-dibromo-8-hydroxyquinoline (x = 1), QH<sup>2</sup> = 1,10-phenanthroline. Cytotoxicity was assessed using the cell counting kit-8 assay, and the results showed that <strong>CaQ1</strong>–<strong>CaQ6</strong> exhibited greater selectivity toward cisplatin-resistant SK-OV-3/DDP ovarian (cis-SK3) cancer cells compared to both nontumorigenic HL-7702 liver cells and parental SK-OV-3 ovarian cancer cells. Notably, <strong>CaQ1</strong> and <strong>CaQ2</strong>, which contain the active H-QM<sup>1</sup>, H-QM<sup>2</sup>, and QH<sup>1</sup> ligands, showed the most potent cytotoxicity, with IC<sub>50</sub> values of 3.59 ± 0.67 μM and 2.73 ± 0.25 μM, respectively, against cis-SK3 cells. Apoptosis induced by <strong>CaQ1</strong> and <strong>CaQ2</strong> was mediated by mitophagy activation and adenosine triphosphate depletion, with <strong>CaQ2</strong> being more effective than <strong>CaQ1</strong>—likely due to the presence of QM<sup>2</sup> and QH<sup>1</sup> ligands in the <strong>CaQ2</strong> complex. In conclusion, these findings suggest that the synthesized 8-hydroxyquinoline-based binuclear calcium(II)-1,10-phenanthroline complexes (<strong>CaQ1</strong>−<strong>CaQ6)</strong> represent promising Ca(II)-based anticancer drug candidates.</div></div>","PeriodicalId":364,"journal":{"name":"Journal of Inorganic Biochemistry","volume":"274 ","pages":"Article 113055"},"PeriodicalIF":3.2000,"publicationDate":"2025-09-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Development of six novel dinuclear calcium(II) complexes based on 8-hydroxyquinoline as anticancer agents\",\"authors\":\"Xiao-Mei Huang , Yue Xu , Si-Mei Qin , Ming-Xiong Tan , Qi-Pin Qin , Tai-Ming Shao , Hong Liang\",\"doi\":\"10.1016/j.jinorgbio.2025.113055\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>This study reports the synthesis and antitumor evaluation of six novel dinuclear calcium(II) complexes with the general formula [Ca<sub>2</sub>(<em>μ</em><sub>2</sub>-O)<sub>2</sub>(QM<sup>x</sup>)<sub>4</sub>(QH<sup>y</sup>)<sub>2</sub>], designated as <strong>CaQ1</strong> through <strong>CaQ6</strong>. These complexes incorporate various deprotonated 8-hydroxyquinoline ligands (H-QM<sup>1</sup>−H-QM<sup>4</sup>) and 1,10-phenanthroline derivatives (QH<sup>2</sup>), synthesized using Ca(NO<sub>3</sub>)<sub>2</sub>·4H<sub>2</sub>O. The specific compositions are as follows: <strong>CaQ1:</strong> H-QM<sup>1</sup> = 5,7-dibromo-8-hydroxyquinoline (x = 1), QH<sup>1</sup> = bathophenanthroline; <strong>CaQ2:</strong> H-QM<sup>2</sup> = 5,7-dichloro-8-quinolinol (x = 2), QH<sup>1</sup> = bathophenanthroline; <strong>CaQ3:</strong> H-QM<sup>3</sup> = 5,7-diiodo-8-hydroxyquinoline (x = 3), QH<sup>2</sup> = 1,10-phenanthroline; <strong>CaQ4:</strong> H-QM<sup>2</sup> = 5,7-dichloro-8-quinolinol (x = 2), QH<sup>2</sup> = 1,10-phenanthroline; <strong>CaQ5:</strong> H-QM<sup>4</sup> = clioquinol (x = 4), QH<sup>2</sup> = 1,10-phenanthroline; <strong>CaQ6:</strong> H-QM<sup>1</sup> = 5,7-dibromo-8-hydroxyquinoline (x = 1), QH<sup>2</sup> = 1,10-phenanthroline. Cytotoxicity was assessed using the cell counting kit-8 assay, and the results showed that <strong>CaQ1</strong>–<strong>CaQ6</strong> exhibited greater selectivity toward cisplatin-resistant SK-OV-3/DDP ovarian (cis-SK3) cancer cells compared to both nontumorigenic HL-7702 liver cells and parental SK-OV-3 ovarian cancer cells. Notably, <strong>CaQ1</strong> and <strong>CaQ2</strong>, which contain the active H-QM<sup>1</sup>, H-QM<sup>2</sup>, and QH<sup>1</sup> ligands, showed the most potent cytotoxicity, with IC<sub>50</sub> values of 3.59 ± 0.67 μM and 2.73 ± 0.25 μM, respectively, against cis-SK3 cells. Apoptosis induced by <strong>CaQ1</strong> and <strong>CaQ2</strong> was mediated by mitophagy activation and adenosine triphosphate depletion, with <strong>CaQ2</strong> being more effective than <strong>CaQ1</strong>—likely due to the presence of QM<sup>2</sup> and QH<sup>1</sup> ligands in the <strong>CaQ2</strong> complex. In conclusion, these findings suggest that the synthesized 8-hydroxyquinoline-based binuclear calcium(II)-1,10-phenanthroline complexes (<strong>CaQ1</strong>−<strong>CaQ6)</strong> represent promising Ca(II)-based anticancer drug candidates.</div></div>\",\"PeriodicalId\":364,\"journal\":{\"name\":\"Journal of Inorganic Biochemistry\",\"volume\":\"274 \",\"pages\":\"Article 113055\"},\"PeriodicalIF\":3.2000,\"publicationDate\":\"2025-09-04\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Inorganic Biochemistry\",\"FirstCategoryId\":\"99\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0162013425002351\",\"RegionNum\":2,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"BIOCHEMISTRY & MOLECULAR BIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Inorganic Biochemistry","FirstCategoryId":"99","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0162013425002351","RegionNum":2,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMISTRY & MOLECULAR BIOLOGY","Score":null,"Total":0}
Development of six novel dinuclear calcium(II) complexes based on 8-hydroxyquinoline as anticancer agents
This study reports the synthesis and antitumor evaluation of six novel dinuclear calcium(II) complexes with the general formula [Ca2(μ2-O)2(QMx)4(QHy)2], designated as CaQ1 through CaQ6. These complexes incorporate various deprotonated 8-hydroxyquinoline ligands (H-QM1−H-QM4) and 1,10-phenanthroline derivatives (QH2), synthesized using Ca(NO3)2·4H2O. The specific compositions are as follows: CaQ1: H-QM1 = 5,7-dibromo-8-hydroxyquinoline (x = 1), QH1 = bathophenanthroline; CaQ2: H-QM2 = 5,7-dichloro-8-quinolinol (x = 2), QH1 = bathophenanthroline; CaQ3: H-QM3 = 5,7-diiodo-8-hydroxyquinoline (x = 3), QH2 = 1,10-phenanthroline; CaQ4: H-QM2 = 5,7-dichloro-8-quinolinol (x = 2), QH2 = 1,10-phenanthroline; CaQ5: H-QM4 = clioquinol (x = 4), QH2 = 1,10-phenanthroline; CaQ6: H-QM1 = 5,7-dibromo-8-hydroxyquinoline (x = 1), QH2 = 1,10-phenanthroline. Cytotoxicity was assessed using the cell counting kit-8 assay, and the results showed that CaQ1–CaQ6 exhibited greater selectivity toward cisplatin-resistant SK-OV-3/DDP ovarian (cis-SK3) cancer cells compared to both nontumorigenic HL-7702 liver cells and parental SK-OV-3 ovarian cancer cells. Notably, CaQ1 and CaQ2, which contain the active H-QM1, H-QM2, and QH1 ligands, showed the most potent cytotoxicity, with IC50 values of 3.59 ± 0.67 μM and 2.73 ± 0.25 μM, respectively, against cis-SK3 cells. Apoptosis induced by CaQ1 and CaQ2 was mediated by mitophagy activation and adenosine triphosphate depletion, with CaQ2 being more effective than CaQ1—likely due to the presence of QM2 and QH1 ligands in the CaQ2 complex. In conclusion, these findings suggest that the synthesized 8-hydroxyquinoline-based binuclear calcium(II)-1,10-phenanthroline complexes (CaQ1−CaQ6) represent promising Ca(II)-based anticancer drug candidates.
期刊介绍:
The Journal of Inorganic Biochemistry is an established international forum for research in all aspects of Biological Inorganic Chemistry. Original papers of a high scientific level are published in the form of Articles (full length papers), Short Communications, Focused Reviews and Bioinorganic Methods. Topics include: the chemistry, structure and function of metalloenzymes; the interaction of inorganic ions and molecules with proteins and nucleic acids; the synthesis and properties of coordination complexes of biological interest including both structural and functional model systems; the function of metal- containing systems in the regulation of gene expression; the role of metals in medicine; the application of spectroscopic methods to determine the structure of metallobiomolecules; the preparation and characterization of metal-based biomaterials; and related systems. The emphasis of the Journal is on the structure and mechanism of action of metallobiomolecules.